Sareum Holdings (LON:SAR) shares advanced around 18% in early deals after it revealed it had ended its equity swap agreement with Yorkville Advisors.
The arrangement, agreed in June 2014, has concluded ahead of schedule, Sareum said.
Yorkville’s Global Master fund will continue to be an ordinary shareholder, the cancer research group added. It holds 21.9mln Sareum shares, which equates to 1.15% of the company.
"We appreciate YAGM's support of Sareum and are pleased to have satisfactorily concluded this agreement," said chief executive Dr Tim Mitchell.
On AIM, Sareum shares gained 0.06p, 18.46%, to trade at 0.38p each.